Furthermore, studies show upregulation of the hemoglobin scavenger receptor CD163 on circulating monocytes and DC3s in patients with severe COVID‐19, possibly reflecting increased maturation [27, 32, 68]. This evidence concerns the gene CD163 and COVID-19.